Intellia Therapeutics Announces Pricing of Public Offering of Common Stock
Intellia Therapeutics priced a public offering of 16,744,187 shares of common stock at $10.75 per share, expecting gross proceeds of approximately $180 million. The underwriters have been granted a 30-day option to purchase up to 2,511,628 additional shares to cover over-allotments. Jefferies, Goldman Sachs & Co.
Key figures
- Deal Value Usd
- approximately $180 million
- Offering Price
- 10.75
- Shares Offered
- 16744187
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.